PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1193428
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1193428
CRISPR Gene Detection and Diagnostic Market size was valued at USD 1,300.7 Million in 2021, expanding at a CAGR of 20.8% from 2022 to 2028.
CRISPR is a method for genome editing that enables researchers to rapidly change DNA sequences and adjust gene function. CRISPR stands for clustered regularly interspaced short palindromic repeats. It offers a wide range of possible uses, including the correction of genetic flaws and the treatment and prevention of disease. Numerous biomedical applications of CRISPR-based diagnostics exist, including the detection of genetic illnesses and the detection of nucleic acid-based biomarkers of infectious and non-infectious diseases.
Market Dynamics
The market for CRISPR gene detection and diagnostic is driven by the rising incidence of chronic diseases. One in three persons have one or more chronic diseases, which are common health disorders. Many people's health and quality of life have been impacted by chronic diseases. Clustered regularly interspaced short palindromic repeats, or CRISPR, is its acronym. CRISPR has developed into a powerful tool for gene editing, which is used to change particular DNA sequences in a cell, in recent years. The study and therapy of muscular dystrophy, cancer, excessive cholesterol, and Huntington's disease all benefit greatly from the use of CRISPR. The range of diagnostics and services available for gene and cell therapies has been expanded by gene editing technologies like the CRISPR-Cas 9 system. Pharmaceutical companies make significant R&D investments to create new drugs, and the use of gene and cell therapy agents is on the rise. This is expected to boost the demand for gene detection and diagnostic in the next few years.
Further, the market for CRISPR gene detection will also rise as a result of improvements in CRISPR gene diagnostics, expanding awareness-raising campaigns by both public and private groups, and rising government support. The demand for efficient treatments is growing, and people are becoming more aware of the importance of early diagnosis, both of which will have a positive effect on the market's growth rate for CRISPR gene detection and diagnostics. Additionally, the market for CRISPR gene identification and diagnostics will grow as a result of increasing disposable income, an increase in chronic diseases, and changing lifestyles.
Segmentation Analysis:
The Global CRISPR Gene Detection and Diagnostic Market is segmented on the basis of Class, Application, End User, and Region.
The market is split into two categories based on Class: Class 1- Multiple Effector Proteins and Class 2 -Single CrRNA-Binding Protein. The Class 1- Multiple Effector Proteins segment dominates the market. Growing demand for gene detection is mainly contributing to segment growth.
The market is segmented into five categories based on application: biomedical diagnostics, genome engineering, drug discovery, agriculture and others. The biomedical diagnostics segment dominates the market and is likely to maintain its dominance during the forecast period. This is partly due to a rise in the demand for biomedical diagnostic treatments and gene detection.
The market is segmented into five categories based on end user: hospitals, diagnostic centers, biotechnology companies, academic and research institutes, and others. The hospital segment dominates the market and is likely to maintain its dominance during the forecast period. This is partly due to an increase in the prevalence of chronic, genetic disorders which, in turn, is boosting the segment growth.
Competitive Landscape:
The worldwide market for CRISPR gene detection and diagnostic is widely fragmented in nature which comprised of large and small-sized market players with few large dominating the global market share. The companies in market emphasize on adopting aggressive strategies to reach out large consumer base. Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new Class launches, partnerships, distribution network development, R&D spending, and mergers and acquisitions.
For instance, In February 2022, Synthego had raised USD 200 million as an investment for research and development to boost the development of CRISPR-Based Medicines from early-phase research to the clinic.
Key features of the study:
This proposed research study on CRISPR Gene Detection and Diagnostic market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2022-2028), considering 2021 as the base year
The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for CRISPR Gene Detection and Diagnostic market
The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the CRISPR Gene Detection and Diagnostic market
Impact of COVID-19 on CRISPR Gene Detection and Diagnostic market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on CRISPR Gene Detection and Diagnostic market post-COVID will also be covered.
In order to give the users of this report a comprehensive view on the CRISPR Gene Detection and Diagnostic market, we have also included competitive landscape and key innovator analysis for the CRISPR Gene Detection and Diagnostic market.
The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the CRISPR Gene Detection and Diagnostic market.
In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
The global CRISPR Gene Detection and Diagnostic market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL CRISPR GENE DETECTION AND DIAGNOSTIC MARKET KEY PLAYERS
Merck KGaA
OriGene Technologies, Inc.
Thermo Fisher Scientific Inc.
Takara Bio Inc.
Horizon Discovery Ltd.
GenScript
BioVision Inc.
Applied StemCell.
GeneCopoeia, Inc.
ToolGen, Inc.
Agilent Technolgies Inc.
Synthego
Cellecta, Inc.
Integrated DNA Technologies, Inc.
New England Biolabs
10x Genomics
CasTag Biosciences
Hera Biolabs
GLOBAL CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY CLASS
Class 1- Multiple Effector Proteins
Class 2 -Single CrRNA-Binding Protein
GLOBAL CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION
Biomedical diagnostics
Genome engineering
Drug discovery
Agriculture
Others
GLOBAL CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY END USER
Hospitals
Diagnostic centers
Biotechnology companies
Academic and research institutes
Others
GLOBAL CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY REGION
North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA